GenoLogics deploys Translational Research Informatics Solution at London’s Top Research Institution – University College London
Victoria, BC, Canada ─ June 24, 2010 ─ GenoLogics today announced it will deploy a comprehensive translational research informatics solution connecting multiple research facilities and biorepositories at University College London (UCL). Connected by a shared vision, GenoLogics will work closely with UCL on one of the largest integrated translational research informatics implementations in the world.
“The critical first step towards our vision, is selecting a leading informatics solution that will facilitate translational research across the complex components of our research effort in Biomedicine and Life Sciences at UCL, and be suitable for extension in due course to our partner hospitals via the UCL Partners Academic Health Science Centre,” commented Professor Ian Jacobs, Dean of Biomedical Sciences at UCL. “This integrated translational research informatics solution from GenoLogics will support our current developments and is well suited for our ambitious longer term informatics goals.”
Dr. Jacky Pallas, Platform Technologies Coordinator at UCL, added, “We are very pleased we found an informatics solution that is flexible enough to provide a common platform for our biorepositories and can accommodate the disparate data structures of our research programs and studies. The GenoLogics solution will provide us with a federating enterprise implementation across UCL and partner hospitals which will help us make our translational research goal a reality.”
UCL will use GenoLogics’ biorepository product suite to create a unified and accessible database and Web portal of biospecimens with standardized clinical annotations. Architected to federate disparate data sources and biobanks, GenoLogics’ biomedical informatics products will allow the entire collection of biospecimens across UCL to be seen as a shared common resource, allowing UCL and external scientists to select biospecimen materials, independent of physical location, for their research.
“Our collaboration with UCL is further validation of our leadership position in translational research informatics. We will deploy the first phase of an end-to-end translational research solution across leading edge facilities and associated biorepositories, with a plan to extend our solution over time,” stated Michael Ball, CEO at GenoLogics.
The reliance on biobanking is increasing worldwide, facilitating the advancement of research into a vast range of health problems. Access to these biorepositories and associated biospecimen data is crucial to ongoing translational research. For the value of sample collections and data to be fully appreciated, ensuring the robust, accurate management of tissue and data repositories is vital. By combining the resources already available at UCL and the informatics solution from GenoLogics in a rationalized model, the full potential of these sample and data sets in the development of new translational advancement of personalized medicine can be realized, not only by those at UCL but by the wider research community.
About UCL
UCL is London’s global university – a research and teaching powerhouse in the heart of one of the most dynamic cities in the world. Focused on the translation of research into solutions to the world’s major problems, UCL works across the disciplines and with partners all over the world. UCL is ranked fourth in the world’s top ten universities by the Times Higher Education-QS World University Rankings. In the 2008, Research Assessment Exercise (RAE) UCL was rated the best research university in London, and third in the UK overall UCL (University College London) is London’s leading multidisciplinary university, with 8,000 staff and 22,000 students, of which more than 4,000 academic and research staff at UCL are dedicated to research and teaching of the highest standards. UCL’s 11 associated teaching hospitals – which include the Great Ormond Street Hospital for Children, the Royal Free Hospital and Moorfields Eye Hospital – provide Londoners with first-rate healthcare as well as contribute to major advances in medical research.
